Results 31 to 40 of about 929 (159)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia

open access: yesCase Reports in Hematology, 2023
VEXAS syndrome stands for vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome. The syndrome is a combined hematological and rheumatological condition caused by a somatic mutation in the UBA1.
Janne Austestad   +5 more
doaj   +1 more source

VEXAS syndrome [PDF]

open access: yesInternational Journal of Hematology, 2022
Kaori Uchino   +9 more
  +5 more sources

Expanding the VEXAS diagnostic workup: the role of peripheral blood cytological analysis

open access: yesFrontiers in Immunology
VEXAS syndrome is a newly described autoinflammatory entity characterized by somatic mutations in the UBA1 X-linked gene in hematopoietic progenitor cells.
Chiara Baggio   +23 more
doaj   +1 more source

The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern

open access: yesReumatismo
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a recently characterized disease associated with somatic mutations in the UBA1 gene, which cause dysregulation of ubiquitin-mediated processes.
C. Iannone   +7 more
doaj   +1 more source

A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma

open access: yesBMC Rheumatology, 2023
Background VEXAS is a recently described inflammatory disease caused by mutations in the UBA1 gene. Symptoms are diverse and include fevers, cartilaginous inflammation, lung inflammation, vasculitis, neutrophilic dermatoses, and macrocytic anemia ...
Khiem T. Vu   +3 more
doaj   +1 more source

Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome

open access: yesFrontiers in Immunology, 2022
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is an inflammatory disorder caused by somatic UBA1 variants, which are sometimes associated with hematological disorders, including myelodysplastic syndrome (MDS).
Haruki Matsumoto   +26 more
doaj   +1 more source

Think VEXAS: a case report of Vexas syndrome

open access: yesJournal of Rare Diseases
AbstractVEXAS syndrome is a rare auto-inflammatory disorder characterized by heterogeneous inflammatory and hematologic features. First identified in 2020, it predominantly affects men over the age of 50. Clinical manifestations commonly include recurrent fever, weight loss, skin lesions, and diverse inflammatory presentations across multiple organ ...
T. Najdi, S. Karaa
openaire   +2 more sources

Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases

open access: yesJournal of Inflammation Research, 2022
Adam Al-Hakim,1 Anoop Mistry,1 Sinisa Savic1,2 1Department of Clinical Immunology and Allergy, St James’s University Hospital, Leeds, UK; 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UKCorrespondence: Sinisa ...
Al-Hakim A, Mistry A, Savic S
doaj  

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

open access: yesInternal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar   +16 more
wiley   +1 more source

Case report: VEXAS syndrome and literature review

open access: yesFrontiers in Hematology
VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a novel disorder first described in 2020. Patients are diagnosed by identifying a somatic mutation of the ubiquitin-like modifier-activating enzyme 1 (UBA1) gene.
Can Jones   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy